Corticosteroids at Time of PD-L1 Blockade May Reduce Efficacy in NSCLC

Taking corticosteroids at the time of treatment initiation with PD-L1 inhibitors may lead to inferior outcomes in patients with non –small-cell lung cancer.

http://www.cancernetwork.com/article/corticosteroids-time-pd-l1-blockade-may-red...

Source: CancerNetwork - September 10, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

More News: Cancer | Cancer & Oncology | Corticosteroid Therapy | Lung Cancer | Non-Small Cell Lung Cancer